A
APGE
Apogee Therapeutics Inc
134.95
+0.10+0.07%After Hours: 134.95 0.00 0.00%17:02 08/26 EDT
OPEN/PREV CLOSE134.83/134.85
TODAY RANGE134.81-134.99
VOL1.61M
MARKET CAP10.21B
52 WEEK RANGE35.39-134.99
AVG VOL (3M)2.73M
% TURNOVER1.99%
TURNOVER--
P/E (TTM)-31.1074
% RANGE0.13%
EPS(TTM)-4.3382
P/E(FORWARD)-28.9435
P/B8.51
BVPS15.86
DIVIDEND--
P/S--
BETA--
DIV YIELD0.00%
FREE FLOAT MKT CAP8.02B
SHARES OUTSTANDING75.69M
NEXT EARNINGS11/09-11/13
FREE FLOAT59.45M
LOT SIZE1
EX-DATE--
News
Press Releases
Financial Reports
Profile
NASDAQ·1d ago
XBI, TWST, ORKA, APGE: Large Inflows Detected at ETF
Seeking Alpha·08/17 12:26
Corcept, Revolution Medicines lead ten large-cap healthcare stocks surging in 2026
TipRanks·08/17 10:16
Apogee Therapeutics downgraded to Neutral from Buy at BTIG
TipRanks·08/17 07:46
Apogee Therapeutics price target raised to $135 from $81 at Truist
TipRanks·08/16 12:39
Soros exits position in Salesforce, cuts Amazon stake
Seeking Alpha·08/14 21:28
Soros adds American Electric Power, exits Salesforce, boosts Entergy stake, among Q2 trades
Dow Jones·08/13 15:56
Apogee Therapeutics Is Maintained at Hold by Truist Securities
TipRanks·08/13 11:57
Apogee Therapeutics (APGE) Receives a Hold from Truist Financial
Benzinga·08/12 16:18
This Apogee Therapeutics Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Wednesday
Dow Jones·08/12 10:39
Apogee Therapeutics Cut to Neutral From Buy by BTIG
Benzinga·08/12 10:29
BTIG Downgrades Apogee Therapeutics to Neutral
TipRanks·08/12 01:45
RBC Capital Sticks to Their Hold Rating for Apogee Therapeutics (APGE)
Same Industry
Name/Symbol
Change%
Price